Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
A cell-to-patient machine learning transfer approach uncovers novel basal-like breast cancer prognostic markers amongst alternative splice variants
Jean-Philippe Villemin et al.
BMC BIOLOGY (2021)
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine
Zi-Hang Chen et al.
CANCER COMMUNICATIONS (2021)
A network approach reveals driver genes associated with survival of patients with triple-negative breast cancer
Courtney D. Dill et al.
ISCIENCE (2021)
Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma
Meng-Xiang Li et al.
BMC CANCER (2021)
Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer
Chen Chen et al.
SCIENTIFIC REPORTS (2021)
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
Balazs Gyorffy
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
KEGG: integrating viruses and cellular organisms
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2021)
Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics
Musalula Sinkala et al.
SCIENTIFIC REPORTS (2020)
Analysis of gene expression profiles of lung cancer subtypes with machine learning algorithms
Fei Yuan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
The transcriptional repressor BCL11A promotes breast cancer metastasis
Darcie D. Seachrist et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
Chengheng Liao et al.
CANCER DISCOVERY (2020)
Machine learning analysis identifies genes differentiating triple negative breast cancers
Charu Kothari et al.
SCIENTIFIC REPORTS (2020)
Molecular classification of breast cancer: A retrospective cohort study
Fatma Khinaifis Al-thoubaity
ANNALS OF MEDICINE AND SURGERY (2020)
Medical Health Big Data Classification Based on KNN Classification Algorithm
Wenchao Xing et al.
IEEE ACCESS (2020)
Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis
Qixi Zhai et al.
BREAST CANCER (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98
Kevin H. Kensler et al.
BREAST CANCER RESEARCH (2019)
Alternative empirical Bayes models for adjusting for batch effects in genomic studies
Yuqing Zhang et al.
BMC BIOINFORMATICS (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations
Matthew H. Bailey et al.
CELL (2018)
Feature selection in machine learning: A new perspective
Jie Cai et al.
NEUROCOMPUTING (2018)
Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014
Mary C. Schroeder et al.
ONCOLOGIST (2018)
Metastatic and triple-negative breast cancer: challenges and treatment options
Sumayah Al-Mahmood et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway
Khoa Nguyen et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Molecular Classification of Breast Cancer
Elena Provenzano et al.
PET CLINICS (2018)
Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer
Rui Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
Xiaoxian Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2017)
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies
Carsten Denkert et al.
LANCET (2017)
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
Charli Dominguez et al.
SEMINARS IN CANCER BIOLOGY (2017)
An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancer
Su Bin Lim et al.
NATURE COMMUNICATIONS (2017)
Breast Cancer: A Molecular and Redox Snapshot
Deepika Raman et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
POU2AF1 Functions in the Human Airway Epithelium To Regulate Expression of Host Defense Genes
Haixia Zhou et al.
JOURNAL OF IMMUNOLOGY (2016)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Calpain in Breast Cancer: Role in Disease Progression and Treatment Response
Sarah J. Storr et al.
PATHOBIOLOGY (2015)
BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells
Walid T. Khaled et al.
NATURE COMMUNICATIONS (2015)
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
Wenting Xu et al.
CELL ADHESION & MIGRATION (2015)
Predicting response and survival in chemotherapy-treated triple-negative breast cancer
A. Prat et al.
BRITISH JOURNAL OF CANCER (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Increased Notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells
Oh-Joon Kwon et al.
NATURE COMMUNICATIONS (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification
Ben-yuan Jiang et al.
MOLECULAR CANCER (2013)
IntOGen-mutations identifies cancer drivers across tumor types
Abel Gonzalez-Perez et al.
NATURE METHODS (2013)
DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions
Alessandra Insinga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Clinicopathologic Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network
Nancy U. Lin et al.
CANCER (2012)
Bcl11a is essential for lymphoid development and negatively regulates p53
Yong Yu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Strategies for aggregating gene expression data: The collapseRows R function
Jeremy A. Miller et al.
BMC BIOINFORMATICS (2011)
Triple negative breast cancer: unmet medical needs
Sumanta Kumar Pal et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Role of Rho GTPases and their regulators in cancer progression
Rajamani Rathinam et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Frozen robust multiarray analysis (fRMA)
Matthew N. McCall et al.
BIOSTATISTICS (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network
Yun Dai et al.
CLINICAL CANCER RESEARCH (2010)
New Approach for M-Cell-Specific Molecules Screening by Comprehensive Transcriptome Analysis
Gaiu Nakato et al.
DNA RESEARCH (2009)
NF-kappa B activation in endothelial cells is critical for the activity of angiostatic agents
Sebastien P. Tabruyn et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
Steffen Durinck et al.
NATURE PROTOCOLS (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
Anoikis: A necessary death program for anchorage-dependent cells
Paola Chiarugi et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer
J. S. Yu et al.
ONCOGENE (2008)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
OCA-B regulation of B-cell development and function
MA Teitell
TRENDS IN IMMUNOLOGY (2003)
Bcl11a is essential for normal lymphoid development
PT Liu et al.
NATURE IMMUNOLOGY (2003)
An automated method for finding molecular complexes in large protein interaction networks
GD Bader et al.
BMC BIOINFORMATICS (2003)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
